Diligence memo · auto-generated · as of July 2, 2026
Atropos Health Inc
Atropos Health Inc looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Atropos Health Inc operates in Healthtech, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Atropos Health Inc has raised $44M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $33M on 2024-05-20.
Most recent recorded round closed around 2024-05-20.
Valuation (modeled)modeled
Provath models Atropos Health Inc at approximately $233M (range $78M–$426M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.41× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era. Within the normal band (141% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 2.1 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 9.9× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 89% of Healthtech peers (2138 compared).
Modeled value ranks above 88% of those peers.
Closest niche peers: Casana Care, Inc., Mendel Health Inc., Bicycle Health Inc., Brave Health, Inc., Flume Health, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.